Simon GE. (N Engl J Med 2006; 355: 2722-3)
Il rischio di idee, comportamenti o tentativi di suicidio è risultato il doppio nei trattati con uno degli antidepressivi più recenti (4%) rispetto al placebo (2%).
Related posts
MIAMI, FL - MARCH 23: Bottles of antidepressant pills Wellbutrin (L-R) , Paxil, Lexapro, Effexor, Zoloft and Fluoxetine are shown March 23, 2004 photographed in Miami, Florida. The Food and Drug Administration asked makers of popular antidepressants to add or strengthen suicide-related warnings on their labels as well as the possibility of worsening depression especially at the beginning of treatment or when the doses are increased or decreased. (Photo Illustration by Joe Raedle/Getty Images)
24 Giugno 2020
